The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 4.1% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 36%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (1 analysts) rates it buy, with a mean price target of $4.
Galiano Gold Inc.
GAU · NYSE American · USD · Market cap $549M
Galiano Gold Inc.
PASS · Titan Ethical · score 91.7Price as of 30 Oct 2026Daily close, not a live quote
Screened 2026-10-30 · the tape above runs as of 12:03 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price1.94 USD at the 30 Oct 2026 close
- Our ratingStrong opportunity, current read markup
- Ethical screenPasses, score 91.7 out of 100
- OptionsOpen interest leans heavily to calls (put/call 0.08)
- Last reviewed30 Oct 2026 (2 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
What this means: price 1.94 against the desk's fair-value range, base estimate 2.62, over the last year.
- Trend Markup
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.08, read 2026-11-01
- Ethical passes the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markup label.
Galiano Gold Inc. holds its Markup at $1.94. The statistical read favours the buyers, held for 140 days.
| Phase | Markup |
| Quantitative state | The statistical read favours the buyers, held for 140 days |
| Price at the screen | $1.94 |
| Valuation | 7.78 trailing · 2.69 forward price to earnings |
| Values screen | PASS · score 91.7 |
| Beta | 1.63 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 5.44% | Below 33% | Interest-bearing debt is just 5.4% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 16.57% | Below 33% | Cash held in interest-bearing accounts and securities is 16.6% of assets, under the one-third limit. | Pass |
| Receivables | 0.00% | Below 49% | Money owed to the company is 0.0% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.76% | Below 5% | Only 0.8% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Clears, in Plain English
Galiano Gold clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 5%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-10-31. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when GAU's ethical verdict changes
Today GAU passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads STRONG OPPORTUNITY: it trades at roughly a 35% discount to our $2.62 fair value, weak competitive moat, 116.70% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-10-30 screen. The gold marker is the market price at the same screen. A 35.0% margin of safety to the base estimate.
Third-party analyst targets: 2 covering, consensus Strong Buy. The average target sits +98% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-30 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsWhy it stands out
A 117%-growth business trading at just 2.7x forward earnings, with a weak competitive moat and minimal debt. That is a 35% discount to our $2.62 fair value: the market is pricing it cautiously while the fundamentals argue otherwise. 2 analysts rate it Strong Buy with a $3.85 average target, about 98% above the screened price.
| Forward P/E | 2.7xcheap for a company growing this fast |
| Trailing P/E | 7.8xvery cheap relative to earnings |
| EPS, trailing | 0.27 |
| EPS, forward | 0.78 |
| Revenue growth | +116.7%growing very fast |
| Profit margin | 13.7%thin but positive margins |
| Return on equity | 28.9%an exceptional return on shareholder capital |
| FCF yield | 1.41% |
| Debt to equity | 0.23minimal debt: a conservative balance sheet |
| Current ratio | 1.23adequate liquidity, worth monitoring |
| Beta | 1.63much more volatile than the market |
| Short interest, float | 0.01% |
| 52-week range | 1.66 - 3.62 |
| Moat | WEAK |
| Market cap | $549M |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day; its business and earnings are exposed to Canada and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeGAU trades on NYSE American (the company is based in Canada). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 36%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (1 analysts) rates it buy, with a mean price target of $4.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 9.5% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading neutral. Over the past year the shares are up 36%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (1 analysts) rates it buy, with a mean price target of $4.
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 9.5% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading neutral. Over the past year the shares are up 36%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (1 analysts) rates it buy, with a mean price target of $4.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 28.5% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading neutral. Over the past year the shares are up 36%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (1 analysts) rates it buy, with a mean price target of $4.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 15.3% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading neutral. Over the past year the shares are up 36%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (1 analysts) rates it buy, with a mean price target of $4.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading neutral. Over the past year the shares are up 36%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (1 analysts) rates it buy, with a mean price target of $4.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score (92). The risk-adjusted return profile shows good risk-adjusted returns.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: PASS with near-perfect ethical score (92). The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Galiano Gold Secures Lease Extensions to Support Asanko Mine Growth Yahoo Finance · 12d ago
- Galiano Gold Provides Notice of Third Quarter 2026 Results Yahoo Finance · 19d ago
- Galiano Gold Secures Long-Term Extension of Key Mining Leases at the Asanko Gold Mine Yahoo Finance · 24d ago
- Galiano Gold Targets Production Growth as Nkran Grades, Hedge Roll-Off Boost Cash Flow Yahoo Finance · 28d ago
- Gold Stocks Retail Investors Are Watching As Bond Yields Test The Case For Bullion Yahoo Finance · 23 Sep 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-19 | Wright (Paul Nicholas) | Director of Issuer | 50,000 | $108,500 | |
| 2026-03-31 | Gregersen (Sean) | Senior Officer of Issuer | 40,000 | $24,440 | |
| 2026-03-31 | Gregersen (Sean) | Senior Officer of Issuer | 54,666 | $48,707 | |
| 2026-03-31 | Gregersen (Sean) | Senior Officer of Issuer | 21,666 | $28,035 | |
| 2026-03-31 | Gregersen (Sean) | Senior Officer of Issuer | 116,332 | $289,317 | |
| 2026-03-16 | Wright (Paul Nicholas) | Director of Issuer | 25,000 | $63,925 | |
| 2026-03-02 | Pettman (Christopher Charles) | Senior Officer of Issuer | 15,000 | $13,605 | |
| 2026-03-02 | Pettman (Christopher Charles) | Senior Officer of Issuer | 15,000 | $52,650 | |
| 2026-02-27 | Pettman (Christopher Charles) | Senior Officer of Issuer | 7,333 | · | |
| 2026-02-24 | Badylak (Maciej) | Senior Officer of Issuer | 628,894 | $711,279 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $2.66 | -27.6% | · | $724 | -27.6% |
| 2 months | $2.70 | -28.7% | · | $713 | -28.7% |
| 3 months | $2.91 | -33.9% | · | $662 | -33.9% |
| 6 months | $2.50 | -23.0% | · | $770 | -23.0% |
| 1 year | $1.42 | +35.6% | · | $1,356 | +35.6% |
| 2 years | $1.62 | +18.8% | · | $1,188 | +18.8% |
| 3 years | $0.58 | +231.9% | · | $3,319 | +231.9% |
| 5 years | $1.23 | +56.5% | · | $1,565 | +56.5% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever GAU does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.